Home > Healthcare > Pharmaceuticals > Finished Drug Form > Antacids Market

Antacids Market Share

Report ID: GMI9703
Published Date: May 2024
Report Format: PDF

Download Free Sample

Antacids Market Share

The antacids industry is highly competitive, marked by several players striving for market dominance. Providers offer comprehensive storage and analysis with improved efficiency and affordability. This includes advancements in processing, precision, automation, and customization. Competition is driven by factors such as the quality, reliability, and ease of usage along with integration capabilities with existing technologies, and compliance with regulatory standards. Strategic partnerships with companies and healthcare networks play a crucial role in market positioning.

Antacids Market Companies

Some of the eminent market participants operating in the antacids industry include:

Aurobindo Pharma Limited
Bayer AG
Bristol Myers Squibb Company
Cipla Limited
Dr. Reddy’s Laboratories Ltd.
F. Hoffmann-La Roche Ltd.
Gsk plc
Hikma Pharmaceuticals PLC
Lupin Limited
Novartis AG
Pfizer Inc.
Sun Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd
The Procter & Gamble Company
Viatris Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global antacids industry size was valued at USD 7.1 billion in 2023 and is estimated to grow at 5.1% CAGR from 2024 to 2032 due to rising prevalence of gastrointestinal disorders and increasing pharmaceutical advancements.

The tablets segment of the market is forecasted to reach USD 6.4 billion by 2032 as they are compact and lightweight, easy to swallow, and convenient dosage form for antacids, providing a standardized and easily measurable dose of medication.

The hospital pharmacy segment of the market accounted for USD 2.2 billion in 2023 as they provide tailored antacid treatments and urgent care for gastrointestinal issues, enhancing patient outcomes and driving market growth through specialized medication management.

Aurobindo Pharma Limited, Bayer AG, Bristol Myers Squibb Company, Cipla Limited, Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche Ltd., Gsk plc, Hikma Pharmaceuticals PLC, and Lupin Limited, among others.